Quest Diagnostics Incorporated - Denver — Denver, Colorado

Quest Diagnostics Incorporated - Denver is a clinical research site located in Denver, Colorado, United States 80209.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Quest Diagnostics Incorporated - Denver has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Cutaneous Melanoma, Non-small Cell Lung Cancer, Colorectal Neoplasms.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Quest Diagnostics Incorporated - Denver?

Quest Diagnostics Incorporated - Denver has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Quest Diagnostics Incorporated - Denver conducted?

Quest Diagnostics Incorporated - Denver has 1 clinical trials on record, with 1 currently active. Their work covers Cutaneous Melanoma, Non-small Cell Lung Cancer, Colorectal Neoplasms.

Is Quest Diagnostics Incorporated - Denver accredited by Crixeo Health?

Quest Diagnostics Incorporated - Denver has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Quest Diagnostics Incorporated - Denver?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.